Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC – a phase II trial

Single-agent therapy with Docetaxel or Pemetrexed is the current therapy of choice for second-line treatment in advanced non-small-cell lung cancer (NSCLC). The role of older agents was underattended over the last years. This study presents the combination of Mitomycin C and Vinorelbine in pretreate...

Descripción completa

Detalles Bibliográficos
Autores principales: Babiak, A, Hetzel, J, Godde, F, König, H-H, Pietsch, M, Hetzel, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360135/
https://www.ncbi.nlm.nih.gov/pubmed/17353918
http://dx.doi.org/10.1038/sj.bjc.6603683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360135/
https://www.ncbi.nlm.nih.gov/pubmed/17353918
http://dx.doi.org/10.1038/sj.bjc.6603683

Ejemplares similares